Table 4.
Summary of antibody isotype positivity cutoff titer in selected studies
Country | IgG positivity cutoff titer | Studies (n) | References | |||||||
---|---|---|---|---|---|---|---|---|---|---|
≥ 1:40 | 1:64 | ≥ 1:64 | ≥ 1:80 | ≥ 1:128 | > 1:128 | ≥ 1:960 | > 1:960 | |||
Brazil | 1 | 1 | 45 | |||||||
China | 1 | 1 | 77 | |||||||
Cyprus | 1 | 1 | 78 | |||||||
France | 1 | 1 | 40 | |||||||
Germany | 1 | 1 | 79 | |||||||
Greece | 1 | 1 | 1 | 3 | 48,80,81 | |||||
Nepal | 1 | 1 | 82 | |||||||
New Zealand | 1 | 1 | 39 | |||||||
Spain | 1 | 2 | 1 | 4 | 14,37,58,61 | |||||
Sri Lanka | 1 | 1 | 83 | |||||||
Tunisia | 1 | 1 | 2 | 19,69 | ||||||
United States | 1 | 2 | 1 | 4 | 84,70,71,85 | |||||
Total (n) | 2 | 2 | 4 | 2 | 5 | 2 | 2 | 2 | 21 |
Country | IgM positivity cutoff titer | Studies (n) | References | |||||||
---|---|---|---|---|---|---|---|---|---|---|
≥ 1:32 | ≥ 1:40 | ≥ 1:64 | > 1:64 | ≥ 1:80 | > 1:80 | ≥ 1:400 | > 1:400 | |||
Brazil | 1 | 1 | 45 | |||||||
China | 1 | 1 | 79 | |||||||
Colombia | 1 | 1 | 88 | |||||||
Cyprus | 1 | 1 | 78 | |||||||
France | 1 | 1 | 40 | |||||||
Greece | 1 | 1 | 2 | 4 | 48,80,81,87 | |||||
Indonesia | 1 | 1 | 88 | |||||||
Israel | 1 | 1 | 28 | |||||||
Lao PDR | 1 | 1 | 2 | 50,75 | ||||||
Nepal | 1 | 1 | 16 | |||||||
Spain | 1 | 1 | 56 | |||||||
Sri Lanka | 1 | 1 | 83 | |||||||
Taiwan | 5 | 1 | 6 | 63,89,90,91,92,93 | ||||||
Tanzania | 1 | 1 | 65 | |||||||
Tunisia | 3 | 1 | 4 | 19,68,67,69 | ||||||
United States | 1 | 1 | 94 | |||||||
Zambia | 1 | 1 | 73 | |||||||
Total (n) | 4 | 2 | 8 | 3 | 5 | 1 | 4 | 2 | 29 |
Country | Whole antibody positivity cutoff titer | Studies (n) | References | |||||||
---|---|---|---|---|---|---|---|---|---|---|
≥ 1:32 | ≥ 1:50 | > 1:50 | ≥ 1:64 | ≥ 1:100 | ≥ 1:200 | ≥ 1:400 | ≥ 1:800 | |||
Israel | 1 | 1 | 74 | |||||||
Lao PDR | 1 | 1 | 76 | |||||||
Malaysia | 1 | 1 | 53 | |||||||
Tanzania | 1 | 1 | 66 | |||||||
Thailand | 1 | 1 | 2 | 95 | ||||||
Tunisia | 1 | 1 | 67 | |||||||
Zambia | 1 | 1 | 73 | |||||||
Total (n) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
* If the positivity cutoff titer was only seen once, then it was not included on the table.
† Studies performed on travelers were excluded.